What's going on in today's pre-market session
By Mill Chart
Last update: Apr 19, 2024
Friday's pre-market session: top gainers and losers
Pre-market gainers
| Ticker | Change | Comment |
|---|---|---|
| ZCMD | 98.62% | ZHONGCHAO INC-CLASS A (NASDAQ:ZCMD) recorded a 98.62% increase in share price during the pre-market session, reaching $2.88 on Friday. In the last 3 months the stock lost 55.29%. |
| AULT | 62.74% | AULT ALLIANCE INC (NYSEARCA:AULT) rose 62.74% to $0.39 during Friday's pre-market session. A press release (Ault Alliance Has Received an Investment of $44 Million to Date from Ault & Company under the November 2023 Securities Purchase Agreement) was released earlier today. |
| EGOX | 30.56% | NEXT.E.GO NV's (NASDAQ:EGOX) shares rose 30.56% to $0.05 during Friday's pre-market session. After recording a 12.15% gain in the previous session, NASDAQ:EGOX maintains its positive trajectory in today's pre-market, with an additional 30.56% increase. |
| LIFWW | 28.0% | MSP RECOVERY INC -27's (NASDAQ:LIFWW) shares rose 28.0% to $0.01 during Friday's pre-market session. Shareholders saw the stock price going 35.14% higher in the past month. |
| TPET | 27.9% | TRIO PETROLEUM CORP's (NYSEARCA:TPET) shares rose 27.9% to $0.42 during Friday's pre-market session. The stock is trading 212.0% higher than a month ago. |
| WLGS | 26.0% | WANG & LEE GROUP INC (NASDAQ:WLGS) recorded a 26.0% increase in share price during the pre-market session, reaching $0.63 on Friday. The stock is trading 23.08% lower than a month ago. |
| RR | 20.15% | Pre-market trading on Friday showed positive momentum for RICHTECH ROBOTICS INC-CL B (NASDAQ:RR), as the stock price advanced 20.15% to reach $1.61. The stock is trading 20.24% lower than a month ago. |
| KA | 17.26% | KINETA INC (NASDAQ:KA) rose 17.26% to $0.57 during Friday's pre-market session. In the last 3 months the share price dropped with 82.51%. |
| RMCO | 16.5% | ROYALTY MANAGEMENT HOLDING C's (NASDAQ:RMCO) shares rose 16.5% to $1.2. Shareholders saw the stock price going 37.58% lower in the past 3 months. |
| ALGS | 16.0% | During Friday's pre-market session, ALIGOS THERAPEUTICS INC (NASDAQ:ALGS) experienced a 16.0% increase, with the stock price reaching $0.92. The stock is trading 21.48% lower than a year ago. |
To see the full list of premarket gainers you can use our premarket gainers page.
Pre-market losers
| Ticker | Change | Comment |
|---|---|---|
| DCFC | -62.36% | TRITIUM DCFC LTD's (NASDAQ:DCFC) shares fell 62.36% to $1.37 during Friday's pre-market session. In the last month the share price dropped with 73.62%. |
| NXL | -23.81% | NEXALIN TECHNOLOGY INC's (NASDAQ:NXL) shares fell 23.81% to $1.12. Despite a promising gain of 11.36% yesterday, NASDAQ:NXL faces downward pressure with a 23.81% decline in today's pre-market session. |
| BGLC | -23.76% | The stock price of BIONEXUS GENE LAB CORP (NASDAQ:BGLC) is declining by 23.76%, reaching $0.65 during Friday's pre-market session. Prices are quite volatile now: this is a reversal from yesterday's 34.0% gain. Yesterday the company had a press release: BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare. |
| TIRX | -17.5% | Today's pre-market session reveals a 17.5% decline in the stock price of TIAN RUIXIANG HOLDINGS LTD-A (NASDAQ:TIRX), now priced at $0.66. Prices are quite volatile now: this is a reversal from yesterday's 65.02% gain. |
| AGBA | -17.48% | AGBA GROUP HOLDING LTD's (NASDAQ:AGBA) stock price decreased by 17.48% to $0.85. Following yesterday's notable 157.0% increase, NASDAQ:AGBA undergoes a 17.48% decrease in today's pre-market session, suggesting a temporary pullback. A press release (AGBA and Triller Merge to Create a $4 Billion Powerhouse, Unleashing a Game-Changing Power in Digital Content and Financial Services) was released yesterday. |
| ISPC | -17.32% | ISPECIMEN INC's (NASDAQ:ISPC) stock price recorded a 17.32% decrease, falling to $0.35. Following yesterday's gain of 97.65%, NASDAQ:ISPC experiences a 17.32% decrease in today's pre-market session, indicating a pullback from the previous session's performance. |
| BTOG | -15.77% | The pre-market session on Friday witnessed a 15.77% decrease in BIT ORIGIN LTD's (NASDAQ:BTOG) shares, with the stock price falling to $2.51. The stock is trading 45.62% lower than a month ago. |
| BPTS | -14.11% | BIOPHYTIS SA-ADR's (NASDAQ:BPTS) shares experienced a 14.11% decline, falling to $0.28 during Friday's pre-market session. Despite a promising gain of 12.26% yesterday, NASDAQ:BPTS faces downward pressure with a 14.11% decline in today's pre-market session. |
| MRDB | -13.46% | Today's pre-market session reveals a 13.46% decline in the stock price of MARIADB PLC (NYSE:MRDB), now priced at $0.36. In the last month the stock gained 67.96%. |
| SPEC | -12.6% | Despite yesterday's decline, SPECTAIRE HOLDINGS INC (NASDAQ:SPEC) experienced a further 12.6% decrease in share price during Friday's pre-market session, reaching $0.54. The struggles persist for NASDAQ:SPEC as it recorded a -20.52% decline during the regular session yesterday, indicating that the challenging days are not yet over. |
For the full premarket loser list go to our premarket losers page.
ALIGOS THERAPEUTICS INC
NASDAQ:ALGS (4/29/2024, 7:00:00 PM)
After market: 0.7356 +0 (+0.25%)0.7338
-0.05 (-6.16%)
ALGS News
5 days ago - Aligos TherapeuticsAligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 StudyData demonstrates a 7-day treatment regimen with the pan-coronavirus protease inhibitor ALG-097558 was well tolerated and does not require ritonavir...
5 days ago - Aligos TherapeuticsAligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD
11 days ago - ChartmillWhat's going on in today's pre-market sessionFriday's pre-market session: top gainers and losers
21 days ago - Aligos TherapeuticsAligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024a month ago - Aligos TherapeuticsAligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjectsa month ago - Aligos TherapeuticsAligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 StudiesSOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical...
a month ago - Aligos TherapeuticsAligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects2 months ago - Aligos TherapeuticsAligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial ResultsSOUTH SAN FRANCISCO, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical...
2 months ago - Aligos TherapeuticsAligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024
